Filter by: patients
Home > Community Treatment Reports and Side Effects > Levetiracetam Treatment Report
What is Levetiracetam?

Levetiracetam is is an anticonvulsant used in combination with other medications to treat partial onset, myoclonic, and/or primary generalized tonic-clonic seizures.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Epilepsy 877 334 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Seizures 70 13 Efficacy_major Efficacy_moderate Efficacy_none Efficacy_cant_tell
Seizures (grand mal or tonic-clonic) 48 24 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Seizures (complex partial) 36 17 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Other 30 4 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Seizures (partial focal) 18 3 Efficacy_moderate Efficacy_slight Efficacy_cant_tell

See all 1013 patients currently taking Levetiracetam

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 74
Moderate
 129
Mild
 121
None
 82

Commonly reported side effects, conditions, and hospitalizations associated with Levetiracetam

Fatigue 32
Excessive daytime sleepiness (somnolence) 21
Sleepiness 20
Depressed mood 17
Dizziness 17
Memory problems 17
See all 232 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Levetiracetam. See all 72 dosages ►

  250 mg daily 500 mg daily 750 mg daily 1,000 mg daily 1,500 mg daily 2,000 mg daily 2,250 mg daily 2,500 mg daily 3,000 mg daily 4,000 mg daily
  22 Number of Patients: 22 114 Number of Patients: 114 24 Number of Patients: 24 220 Number of Patients: 220 136 Number of Patients: 136 165 Number of Patients: 165 14 Number of Patients: 14 41 Number of Patients: 41 179 Number of Patients: 179 43 Number of Patients: 43  

Reported Stop Reasons

Why Patients Stopped Taking Levetiracetam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 126   Side effects too severe: 49%
Did not seem to work 95   Did not seem to work: 37%
Doctor's advice 77   Doctor's advice: 30%
Other 29   Other: 11%
Expense 20   Expense: 8%
Course of treatment ended 12   Course of treatment ended: 5%
Personal research 11   Personal research: 4%
Not indicated 6   Not indicated: 2%
Change in health plan coverage 4   Change in health plan coverage: 2%

See all 252 patients who’ve stopped taking Levetiracetam

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Levetiracetam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Levetiracetam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Levetiracetam

Always
 363 89%
Usually
 31 8%
Sometimes
 3 1%
Never
 9 2%

Burden

Difficulty being on treatment

Burden of Levetiracetam

Very
 24 6%
Somewhat
 38 9%
A little
 64 16%
Not at all
 280 69%

Cost

Paid out of pocket

Cost of Levetiracetam

$200+
 16 6%
$100-199
 12 5%
$50-99
 35 14%
$25-49
 32 13%
< $25
 157 62%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.